miR-503 inhibits platelet-derived growth factor-induced human aortic vascular smooth muscle cell proliferation and migration through targeting the insulin receptor

Biomed Pharmacother. 2016 Dec:84:1711-1716. doi: 10.1016/j.biopha.2016.10.081. Epub 2016 Nov 6.

Abstract

Abnormal proliferation and migration of vascular smooth muscle cells (VSMC) is a common feature of disease progression in atherosclerosis. Here, we investigated the potential role of miR-503 in platelet-derived growth factor (PDGF)-induced proliferation and migration of human aortic smooth muscle cells and the underlying mechanisms of action. miR-503 expression was significantly downregulated in a dose- and time-dependent manner following PDGF treatment. Introduction of miR-503 mimics into cultured SMCs significantly attenuated cell proliferation and migration induced by PDGF. Bioinformatics analyses revealed that the insulin receptor (INSR) is a target candidate of miR-503. miR-503 suppressed luciferase activity driven by a vector containing the 3'-untranslated region of INSR in a sequence-specific manner. Downregulation of INSR appeared critical for miR-503-mediated inhibitory effects on PDGF-induced cell proliferation and migration in human aortic SMCs. Based on the collective data, we suggest a novel role of miR-503 as a regulator of VSMC proliferation and migration through modulating INSR.

Keywords: INSR; Migration; Proliferation; VSMCs; miR-503.

MeSH terms

  • 3' Untranslated Regions
  • Antigens, CD / genetics
  • Antigens, CD / metabolism*
  • Aorta / drug effects
  • Aorta / metabolism
  • Aorta / pathology
  • Becaplermin
  • Binding Sites
  • Cell Cycle Checkpoints / drug effects
  • Cell Movement / drug effects*
  • Cell Proliferation / drug effects*
  • Computational Biology
  • Dose-Response Relationship, Drug
  • Down-Regulation
  • HEK293 Cells
  • Humans
  • MicroRNAs / genetics
  • MicroRNAs / metabolism*
  • Muscle, Smooth, Vascular / drug effects*
  • Muscle, Smooth, Vascular / metabolism
  • Muscle, Smooth, Vascular / pathology
  • Myocytes, Smooth Muscle / drug effects*
  • Myocytes, Smooth Muscle / metabolism
  • Myocytes, Smooth Muscle / pathology
  • Proto-Oncogene Proteins c-sis / pharmacology*
  • Receptor, Insulin / genetics
  • Receptor, Insulin / metabolism*
  • Signal Transduction / drug effects
  • Time Factors
  • Transfection

Substances

  • 3' Untranslated Regions
  • Antigens, CD
  • MIRN503 microRNA, human
  • MicroRNAs
  • Proto-Oncogene Proteins c-sis
  • Becaplermin
  • INSR protein, human
  • Receptor, Insulin